Literature DB >> 31939906

An Update on Epidemiology and Management Trends of Vestibular Schwannomas.

Vivek C Pandrangi1, Albert Y Han2, Jose E Alonso2, Kevin A Peng3, Maie A St John2,4,5.   

Abstract

OBJECTIVE: To determine the current epidemiology and management trends for patients with vestibular schwannomas (VS). STUDY
DESIGN: Retrospective cohort study.
SETTING: The Surveillance, Epidemiology, and End Results (SEER) tumor registry. PATIENTS: The SEER database was queried to identify patients diagnosed with VS from 1973 to 2015. Demographics, patient and tumor characteristics, and treatment methods were analyzed.
RESULTS: A total of 14,507 patients with VS were identified. The mean age at diagnosis was 55 ± 14.9 years. Age-adjusted incidence from 2006 to 2015 was 1.4 per 100,000 per year and remained relatively stable. Incidence across age varied with sex, as younger women and older men had increased incidences comparatively. A higher percentage of patients underwent surgery alone (43%), followed by observation (32%), radiation alone (23%), and combined radiation and surgery (2%). Age 65 and older was associated with observation (odds ratio [OR] 1.417; p = 0.029) whereas age 20 to 39 and 40 to 49 were associated with surgery (OR 2.013 and 1.935; p < 0.001). Older age was associated with radiation. Larger tumor size was associated with surgery and combined treatment. African American patients and American Indian or Alaskan Native patients were more likely to undergo observation than surgery.
CONCLUSIONS: The overall incidence of VS is 1.4 per 100,000 per year and has remained relatively stable. There is a trend toward more conservative management with observation, which may be secondary to earlier diagnosis given widespread use of magnetic resonance imaging. Further studies are necessary to investigate differences in disease patterns and disparities in management.

Entities:  

Mesh:

Year:  2020        PMID: 31939906     DOI: 10.1097/MAO.0000000000002542

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  5 in total

1.  Multimode imaging characteristics and treatment of uveal schwannoma.

Authors:  Ting Zhang; Lu-Jia Feng; You Wang; Yun-Hong Shi; Li Wang; Yi-Meng Sun; Yan-Tao Wei; Shao-Chong Zhang
Journal:  Int J Ophthalmol       Date:  2022-03-18       Impact factor: 1.779

Review 2.  Evaluation of Vestibular Function in Diagnosis of Vestibular Schwannomas.

Authors:  Xue-Qing Zhang; Tai-Sheng Chen; Wei Wang
Journal:  Curr Med Sci       Date:  2021-08-17

3.  Potential for selection bias surrounding reporting of benign brain tumors in the United States.

Authors:  John P Marinelli; Matthew L Carlson
Journal:  Neuro Oncol       Date:  2021-06-01       Impact factor: 12.300

Review 4.  New developments in neurofibromatosis type 2 and vestibular schwannoma.

Authors:  Yin Ren; Divya A Chari; Sasa Vasilijic; D Bradley Welling; Konstantina M Stankovic
Journal:  Neurooncol Adv       Date:  2020-11-16

5.  Underreporting of Vestibular Schwannoma Incidence Within National Brain Tumor and Cancer Registries in the United States.

Authors:  John P Marinelli; Ashley M Nassiri; Elizabeth B Habermann; Christine M Lohse; Sara J Holton; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2021-07-01       Impact factor: 2.619

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.